Transcription of HIBOR HIKMA PHARMACEUTICALS - Modern …
{{id}} {{{paragraph}}}
09-15. HIBOR . HIKMA PHARMACEUTICALS . (Bemiparin Sodium) The recommended dose of bemiparin is 2,500 IU/. Action day or 3,500 IU/day by subcutaneous route, HIBOR (Bemiparin sodium) belongs to a group of according to the set of risk factors of the patients, medicines called anticoagulants, which help to pre- whether defined as mild or high-risk thromboem- vent blood from clotting in the blood vessels. bolic patients. HIBOR is a second-generation low molecular weight Prophylactic treatment must be continued, accord- . heparin (LMWH). It has a very low mean molecular ing to the physician's criteria, during the risk period weight (3600 Dalton), a long half life ( hrs) and a or until the complete mobilisation of the patient.
HIKMA-HIBOR - p.2/3 • In case of bacterial Endocarditis. • In patients with active major bleeding (e.g. active stomach ulcer, stroke, brain tumours, or if you have
Domain:
Source:
Link to this page:
Please notify us if you found a problem with this document:
{{id}} {{{paragraph}}}
EPILEPSY AND ANESTHESIA, DRUG ABSORPTION, DISTRIBUTION AND, Brain, Problem of Monitoring for, Problem of Monitoring for Peripheral Vision Loss, Children, DIFFERENCES IN CHRONIC WIDESPREAD PAIN, DIFFERENCES IN CHRONIC WIDESPREAD PAIN AND FIBROMYALGIA, Communicating With Cognitively Impaired, 721566-04 451175A/Revised February 2010